Escitalopram

Primary Indications

Escitalopram is a type of antidepressant known as a selective serotonin reuptake inhibitor (SSRI). It is primarily used to treat the following conditions:

• Major Depressive Disorder: It is used to treat depression in adults and adolescents aged 12 to 17. It helps improve mood and feelings of well-being.
• Generalized Anxiety Disorder: It is used to treat adults who experience persistent and excessive anxiety and worry.

In addition to treating active symptoms, healthcare providers may prescribe escitalopram for maintenance therapy to help prevent the recurrence of symptoms over a longer period.

Mechanism of Action

Escitalopram belongs to a class of medications called selective serotonin reuptake inhibitors (SSRIs). It works by increasing the activity of serotonin in the brain. Serotonin is a neurotransmitter, which is a chemical messenger that helps transmit signals between nerve cells (neurons) and plays a key role in regulating mood, sleep, and emotion.

In the brain, serotonin is released by one nerve cell and then reabsorbed by that same cell after the message is sent. This process is called reuptake. Escitalopram works by:

• Blocking the reabsorption (reuptake) of serotonin into the nerve cells.
• Increasing the amount of serotonin available in the gaps between neurons.
• Strengthening the communication between nerve cells that affect mood.

Selective Action

This medication is considered selective because it primarily affects serotonin and has very little effect on other chemical messengers in the brain, such as norepinephrine or dopamine. This targeted approach helps manage symptoms of depression and generalized anxiety disorder while minimizing certain types of interactions with other brain chemicals.

Time to Effectiveness

While the chemical changes begin shortly after taking the medication, the brain needs time to adjust to these new levels. Most people do not feel the full mood-stabilizing effects immediately. It often takes one to four weeks of consistent use before a person notices a significant improvement in their symptoms.

Common Side Effects

Many people using escitalopram experience mild side effects. These may include:

• Nausea, diarrhea, or constipation
• Sexual problems, such as decreased sex drive or delayed ejaculation
• Drowsiness, tiredness, or dizziness
• Increased sweating
• Dry mouth
• Heartburn or stomach pain
• Loss of appetite or weight changes
• Runny nose or sneezing

Serious Side Effects

Seek medical attention immediately if you experience any of the following serious symptoms:

• Signs of serotonin syndrome: agitation, hallucinations, fever, sweating, confusion, fast or irregular heartbeat, severe muscle stiffness, twitching, shivering, or loss of coordination
• Seizures
• Unusual bleeding or bruising
• Rash, hives, or itching
• Swelling of the face, throat, tongue, or lips
• Difficulty breathing or swallowing
• Vision changes, eye pain, or redness and swelling in or around the eye
• Signs of low sodium levels: headache, confusion, weakness, or feeling unsteady

Suicidal Thoughts and Behaviors

Escitalopram and other antidepressant medicines may increase suicidal thoughts or actions in some children, teenagers, and young adults, especially within the first few months of treatment or when the dose is changed. Families and caregivers should monitor for new or worsening depression, sudden changes in mood, or unusual behaviors.

Serotonin Syndrome

A potentially life-threatening condition called serotonin syndrome can occur, particularly when escitalopram is taken with other medicines that affect serotonin levels. Symptoms may include agitation, hallucinations, rapid heartbeat, dizziness, sweating, flushing, tremors, or stiff muscles.

Heart Rhythm Changes

This medication can cause changes in the electrical activity of the heart, known as QT prolongation. This risk is higher for individuals with certain heart conditions or those taking other medications that affect heart rhythm.

Increased Risk of Bleeding

Escitalopram may increase the risk of bleeding events. This risk is higher if the medication is taken with aspirin, nonsteroidal anti-inflammatory drugs (NSAIDs) like ibuprofen or naproxen, warfarin, or other blood thinners.

Mania and Bipolar Disorder

In people with bipolar disorder, using an antidepressant alone may trigger a mixed or manic episode. It is important to be screened for bipolar disorder before starting treatment.

Discontinuation Symptoms

Stopping escitalopram suddenly can lead to withdrawal-like symptoms, such as dizziness, nausea, headache, irritability, and sleep disturbances. A gradual reduction in dose is typically recommended under medical supervision.

Other Precautions

• Seizures: Use with caution in individuals with a history of seizure disorders.
• Hyponatremia: Low sodium levels in the blood may occur, particularly in older adults or those taking diuretics.
• Angle-Closure Glaucoma: This medication may trigger an acute glaucoma attack in people with certain eye structures who have not had corrective surgery.
• Sexual Dysfunction: Treatment may cause symptoms of sexual dysfunction in both men and women, which may persist in some cases after stopping the medication.

Pregnancy

Decisions regarding the use of escitalopram during pregnancy should be made in consultation with a healthcare provider. It is important to consider both the risks of the medication and the risks of untreated depression or anxiety to both the mother and the developing fetus.

Infants exposed to selective serotonin reuptake inhibitors (SSRIs) like escitalopram late in the third trimester may develop complications shortly after birth. These complications may require prolonged hospitalization, respiratory support, or tube feeding. Reported symptoms in newborns include:

• Respiratory distress or bluish skin color
• Seizures or tremors
• Temperature instability
• Feeding difficulties or vomiting
• Hypoglycemia (low blood sugar)
• Irritability or constant crying
• Stiffness or limpness

There is also evidence suggesting that SSRI use during pregnancy may increase the risk of persistent pulmonary hypertension of the newborn (PPHN), a serious condition affecting the infant's lungs and heart. If you become pregnant while taking escitalopram, do not stop taking the medication abruptly without consulting your doctor, as sudden discontinuation can lead to a relapse of symptoms or withdrawal effects.

Breastfeeding

Escitalopram is excreted into human breast milk. While many nursing infants do not show adverse effects, there have been reports of symptoms such as excessive drowsiness, decreased feeding, and weight loss in infants exposed to the drug through breast milk. Healthcare providers generally weigh the benefits of breastfeeding against the potential risks of infant exposure when determining the best course of treatment.

Available Forms

Escitalopram is administered orally and is available in the following formulations:

• Oral Tablet: A solid medication taken by mouth.
• Oral Solution: A liquid formulation taken by mouth, which may be used as an alternative for those who have difficulty swallowing tablets.

FDA Approval and Indications

Escitalopram was first approved by the U.S. Food and Drug Administration (FDA) in 2002. It is currently approved for the treatment of:

• Major Depressive Disorder (MDD) in adults and adolescents aged 12 to 17 years.
• Generalized Anxiety Disorder (GAD) in adults.

Boxed Warning

The FDA requires a boxed warning for escitalopram and other antidepressant medications. This warning highlights an increased risk of suicidal thinking and behavior in children, adolescents, and young adults (up to age 24) during the initial stages of treatment or when the dose is changed. Patients of all ages starting this medication should be monitored closely for clinical worsening or unusual changes in behavior.

Regulatory Safety Communications

The FDA has issued safety communications regarding potential risks associated with escitalopram, including:

• Serotonin Syndrome: A potentially life-threatening condition that can occur when escitalopram is taken with other serotonergic drugs.
• QT Prolongation: Warnings regarding the risk of abnormal heart rhythms, particularly when used at high doses or in combination with other medications that affect heart rhythm.
• Discontinuation Syndrome: Recommendations to taper the dose gradually rather than stopping abruptly to avoid withdrawal symptoms.

Withdrawal Symptoms

If you stop taking escitalopram abruptly, you may experience a group of symptoms often called discontinuation syndrome. These symptoms can include:

• Dizziness, nausea, and sweating
• Headache and tiredness
• Irritability, agitation, or anxiety
• Confusion or emotional mood swings
• Sleep disturbances, such as insomnia or vivid dreams
• Sensory disturbances, such as tingling or electric shock sensations in the body

Safe Discontinuation

To prevent or reduce withdrawal symptoms, your doctor will usually recommend gradually lowering your dose over a period of several weeks or months. This process is known as tapering.

If you experience severe or intolerable symptoms while reducing your dose, contact your healthcare provider. They may advise you to return to a previously tolerated dose and then decrease the medication even more slowly.